DistantNews
Support us
🇮🇸 Iceland /Economy & Trade

Daði Óskarsson Joins Coripharma’s Executive Management

From Morgunblaðið · () Icelandic

Translated from Icelandic and summarized by DistantNews. Read the original for the full story.

At a glance

Press release Official statement New plan
  • Coripharma appointed Daði Óskarsson as managing director of its product management division.
  • Óskarsson joined the company in 2022 and previously spent 11 years in product management at Medis.
  • He said he looked forward to strengthening the division as Coripharma continues to grow.

Daði Óskarsson has been appointed managing director of Coripharma’s product management division, taking a seat on the Icelandic pharmaceutical company’s executive management team.

Óskarsson joined Coripharma in 2022. He first worked on contract manufacturing projects before moving into business development for the company’s own developed medicines.

Before joining Coripharma, he spent 11 years in product management at Medis. In a company statement, Óskarsson called the new position an exciting opportunity and said he looked forward to building a strong and efficient product management division that would support Coripharma’s continued growth.

Coripharma develops, manufactures and exports generic medicines. The company currently employs about 230 people.

It is a really exciting opportunity to lead Coripharma’s product management division. I look forward to taking on this new role and continuing to build a strong and efficient product management division that supports the company’s continued growth.

— Daði ÓskarssonCommenting on his appointment in a company statement.
About this summary

Originally published by Morgunblaðið in Icelandic. Translated, summarized, and contextualized automatically by DistantNews, with a note on how the source frames the story. Not individually reviewed before publishing. How this works.

More Stories

From Our Blog